MHz, CDCl3): δ -130.0 (dm, 1F, J = 166.0 Hz), -141.6 (ddd, 1F, J = 166.0 Hz, J = 14.4 Hz, J = 5.2Hz). 13C NMR (100 MHz, CDCl3): δ
137.1, 128.8, 127.4, 122.4, 121.2, 120.5, 110.4 (t, J = 284.2 Hz), 109.9, 102.9, 34.3 (dd, J = 16.6 Hz, J = 9.3 Hz), 18.5 (t, J = 10.7 Hz).
IR (cm-1): 3106, 3055, 3018, 2917, 1613, 1517, 1463, 1311, 1232, 1206, 1021, 969. MS (EI) m/z: 193 (M+, 100.00), 192 (70.43), 172
(48.31), 143 (56.55), 142 (20.51), 129 (16.60), 115 (17.78), 89 (19.52). Anal. Calcd. for C11H9F2N: C, 68.39; H, 4.70; N, 7.25. Found: C,
68.21; H, 4.54; N, 7.23.
1
1-(2, 2-Difluorocyclopropyl)-2-methyl-indole 4b: colorless oil (69%). H NMR (300 MHz, CDCl3): δ 7.50 (d, 1H, J = 6.9 Hz), 7.32
(d, 1H, J = 7.3 Hz), 7.01-7.25 (m, 2H), 6.27 (s, 1H), 3.60-3.73 (m, 1H), 2.46 (s, 3H), 1.91-2.28 (m, 2H). 19F NMR (282 MHz, CDCl3): δ -
130.8 (dm, 1F, J = 160.9 Hz), -141.6 (ddd, 1F, J = 160.9 Hz, J = 13.4 Hz, J = 5.1Hz). 13C NMR (100 MHz, CDCl3): δ 138.2, 137.4,
128.7, 121.2, 120.2, 120.1, 110.4 (t, J = 282.9 Hz), 109.8, 101.8, 33.1 (dd, J = 16.7 Hz, J = 9.7 Hz), 18.5 (t, J = 10.6 Hz), 12.78. IR (cm-
1): 3101, 3017, 2994, 2955, 1608, 1557, 1479, 1462, 1393, 1323, 1312, 1241, 1220, 1027, 965. MS (EI) m/z: 207 (M+, 100.00), 206
(46.43), 192 (61.53), 186 (49.25), 172 (37.69), 157 (29.01), 156 (45.29), 115 (46.46). Anal. Calcd. for C12H11F2N: C, 69.55; H, 5.35; N,
6.76. Found: C, 69.61; H, 5.47; N, 6.64.
1
1-(2, 2-Difluorocyclopropyl)-3-aceyl-indole 4c: colorless oil (63%). H NMR (300 MHz, CDCl3): δ 8.36 (m, 1H), 7.72 (s, 1H), 7.28-
7.45 (m, 3H), 3.84-3.99 (m, 1H), 2.50 (s, 3H), 2.12-2.31 (m, 1H), 1.91-2.01 (m, 1H). 19F NMR (282 MHz, CDCl3): δ -129.8 (dm, 1F, J =
162.9 Hz), -140.9 (ddd, 1F, J = 162.9 Hz, J = 14.5 Hz, J = 6.2Hz). 13C NMR (100 MHz, CDCl3): δ 193.09, 134.2, 126.1, 124.0, 124.0
123.2, 122.8, 118.3, 110.1, 109.5 (t, J = 286.3 Hz), 34.4 (dd, J = 16.6 Hz, J = 9.7 Hz), 27.6, 18.5 (t, J = 11.1 Hz). IR (cm-1): 3133, 3106,
3005, 1639, 1533, 1475, 1460, 1381, 1306, 1229, 1216, 1008, 915. MS (EI) m/z: 235 (M+, 59.76), 200 (48.11), 192 (74.05), 172 (100.00),
170 (91.98), 115 (38.60), 87 (55.43), 43 (40.09). Anal. Calcd. for C13H11F2NO: C, 66.38; H, 4.71; N, 5.95. Found: C, 66.53; H, 4.90; N,
5.94.
1
1-(2, 2-Difluorocyclopropyl)benzimidazole 4d: colorless oil (55%). H NMR (300 MHz, CDCl3): δ 7.97 (s, 1H), 7.83 (dm, 1H, J =
5.9Hz), 7.48 (d, 1H, J = 6.8Hz), 7.29-7.48 (m, 2H), 3.85-4.00 (m, 1H), 2.15-2.35 (m, 1H), 1.93-2.10 (m, 1H). 19F NMR (282 MHz,
CDCl3): δ -130.9 (dm, 1F, J = 161.8 Hz), -140.9 (dm, 1F, J = 161.8 Hz). 13C NMR (100 MHz, CDCl3): δ 143.3, 142.6, 134.2, 123.8,
122.8, 120.4, 110.0, 109.5 (t, J = 286.9 Hz), 32.3 (dd, J = 16.6 Hz, J = 10.0 Hz), 18.2 (t, J = 11.0 Hz). IR (cm-1): 3093, 3019, 1615, 1497,
1458, 1369, 1315, 1226, 1105, 1023. MS (EI) m/z: 194 (M+, 100.00), 193 (57.84), 167 (60.84), 144 (36.17), 103 (37.52), 77 (21.50), 76
(48.14), 50 (20.60). Anal. Calcd. for C10H8F2N2: C, 61.85; H, 4.15; N, 14.43. Found: C, 61.84; H, 4.44; N, 14.31.
1
1-(2, 2-Difluorocyclopropyl) -6-nitro-benzimidazole 4e: white solid (54%). H NMR (300 MHz, CDCl3): δ 7.51-8.79 (m, 4H), 3.95-
4.12 (m, 1H), 2.27-2.49 (m, 1H), 1.99-2.18 (m, 1H). 19F NMR (282 MHz, CDCl3): δ -130.3 (dm, 1F, J = 162.9 Hz), -140.9 (dm, 1F, J =
162.9 Hz). 13C NMR (100 MHz, CDCl3): δ 138.2, 137.4, 128.7, 121.1, 120.2, 120.0, 110.3 (t, J = 286.3 Hz), 109.7, 33.0 (dd, J = 16.8 Hz,
J = 9.4 Hz), 18.5 (t, J = 11.0 Hz). IR (cm-1): 3101, 3014, 1619, 1593, 1517, 1482, 1345, 1308, 1226, 1203, 1063, 1023, 966. MS (EI) m/z:
239 (M+, 94.16), 222 (100.00), 193 (43.36), 192 (51.91), 173 (39.64), 102 (28.53), 75 (53.67), 74 (26.49). Anal. Calcd. for C10H7F2N3O2:
C, 50.22; H, 2.95; N, 17.57. Found: C, 49.96; H, 3.22; N, 17.57.
N-(2, 2-Difluorocyclopropyl)phthalimide 4f: white solid (65%). 1H NMR (300 MHz, CDCl3): δ 7.84-7.92 (m, 2H), 7.72-7.79 (m, 2H),
3.22-3.32 (m, 1H), 2.02-2.24(m, 2H). 19F NMR (282 MHz, CDCl3): δ -134.0 (dm, 1F, J = 163.3 Hz), -142.7 (dm, 1F, J = 163.3 Hz).
1
1-(2, 2-Difluorocyclopropyl)benzotriazole 4g: colorless oil (60%). H NMR (300 MHz, CDCl3): δ 8.08 (d, 1H, J = 8.1 Hz), 7.63 (d,
1H, J = 8.1 Hz), 7.56 (dd, 1H, J = 8.1Hz, J = 6.9 Hz), 7.41 (dd, 1H, J = 8.1Hz, J = 6.9 Hz), 4.22-4.39 (m, 1H), 2.58-2.77 (m, 1H), 2.33-
2.52 (m, 1H). 19F NMR (282 MHz, CDCl3): δ -131.2 (dm, 1F, J = 162.8 Hz), -141.9 (ddd, 1F, J = 162.8 Hz, J = 13.5 Hz, J = 7.5 Hz). 13
C
NMR (100 MHz, CDCl3): δ 145.5, 133.6, 127.8, 124.1, 119.8, 108.9, 108.5 (t, J = 285.6 Hz), 34.7 (dd, J = 16.9 Hz, J = 10.3 Hz), 18.5 (t,
J = 11.2 Hz). IR (cm-1): 3109, 3029, 1614, 1495, 1478, 1454, 1316, 1233, 1178, 1099, 1021, 1008, 978. MS (EI) m/z: 166 (35.83), 148
(28.73), 140 (23.56), 103 (73.87), 173 (39.64), 91 (24.60), 76 (100.00), 50 (32.81). Anal. Cald. for C9H7F2N3: C, 55.39; H, 3.62; N,
21.53. Found: C, 55.22; H, 3.69; N, 21.45.
3. Results and discussion
Since tosylate was an excellent leaving group, we assumed gem-difluorocyclopropyl sulfonic esters could be used for direct N-
difluorocyclopylation via simple nucleophilic substitution. So the initial effort was directed towards the synthesis of these building
blocks. Fortunately, gem-difluorocyclopropyl sulfonic esters (2a-2c) could be easily obtained by gem-difluorocyclopropanation of vinyl
sulfonic esters 1a-c with trimethylsilyl fluorosulfonyldifluoroacetate (TFDA), which has proved to be an efficient difluorocarbene
reagent (Scheme 2) [19-20]. Slow addition of TFDA to vinyl sulfonic esters in xylene with a catalytic amount of NaF gave gem-
difluorocyclopyl tosylates in moderate to good yields. The desired products 2a-c could be prepared in gram scale and are stable to air and
water.
O
F
TFDA, NaF
xylene
F
O
S
O
S
R
O
R
O
O
2a: 78%
2b: 80%
2c: 75%
1a: R = Me
1b: R = NO2
1c: R = H
Scheme 2. The synthesis of gem-difluorocyclopropyl sulfonic esters.
Page 4 of 7